- On Good Things Utah this morning – Real Salt Lake remembered and honored the life of the club’s VP of communications and public relations John Genna. On August, 5, Genna passed away at the age of 56 years old. Genna was diagnosed with ALS, a progressive neurological disease also known as Lou Gehrig’s disease, in July 2022. The disease is terminal and has no known cure. John has sat on our set many times, welcomed us to interviews and games at the stadium and was a good friend of Good Things Utah. He will be missed by all of us.
- “His legacy will be remembered more than positively. At Real Salt Lake, his legacy will be remembered forever,” Real Salt Lake shared after Genna’s passing. “John is still somewhere smiling, laughing, and wanting you to know that despite what he was up against, what matters to him now is how you’re doing, and that you know he still loves you.”
- “I want my legacy to be that I can impact the research,” Genna said before his passing. “That one day the next person that comes after me and the doctor opens his mouth and says ‘you have ALS’ they don’t have that sinking feeling that I had. That’s what I want to make my legacy.” Last season, Real Salt Lake players wore “Genna Strong” patches during the team’s regular season finale. Earlier this season, RSL hosted its second consecutive ALS awareness night. Throughout the 2023 campaign, Real Salt Lake head coach Pablo Mastroeni has sported a “Genna Strong” shirt during matches and postgame press conferences. Mastroeni also had Genna speak to the team before a match last season.
- “Unbeknownst to him, a lot of our conversations were carried into the locker room. I think he is a big part of the way I wish to lead and the leader I wish to become,” Mastroeni said of Genna. Over the past six seasons, Genna worked for the club he loved. “Keep loving this team because that love comes back in spades,” said Genna.
- Rest in Peace, John Genna.
Real Salt Lake remembers the life of a special member of the team
Close
Thanks for signing up!
Watch for us in your inbox.
Subscribe Now